114 related articles for article (PubMed ID: 11689216)
1. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.
Karvonen MK; Valkonen VP; Lakka TA; Salonen R; Koulu M; Pesonen U; Tuomainen TP; Kauhanen J; Nyyssönen K; Lakka HM; Uusitupa MI; Salonen JT
Atherosclerosis; 2001 Nov; 159(1):145-51. PubMed ID: 11689216
[TBL] [Abstract][Full Text] [Related]
2. Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.
Järvisalo MJ; Jartti L; Karvonen MK; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Paakkunainen U; Simell O; Raitakari OT; Rönnemaa T
Atherosclerosis; 2003 Apr; 167(2):319-26. PubMed ID: 12818415
[TBL] [Abstract][Full Text] [Related]
3. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
Erkkilä AT; Lindi V; Lehto S; Laakso M; Uusitupa MI
Mol Genet Metab; 2002 Mar; 75(3):260-4. PubMed ID: 11914038
[TBL] [Abstract][Full Text] [Related]
4. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD.
Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
Public Health Nutr; 2008 Nov; 11(11):1156-62. PubMed ID: 18279562
[TBL] [Abstract][Full Text] [Related]
5. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children.
Karvonen MK; Koulu M; Pesonen U; Uusitupa MI; Tammi A; Viikari J; Simell O; Rönnemaa T
J Clin Endocrinol Metab; 2000 Apr; 85(4):1455-60. PubMed ID: 10770181
[TBL] [Abstract][Full Text] [Related]
6. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
Heikkinen AM; Niskanen LK; Salmi JA; Koulu M; Pesonen U; Uusitupa MI; Komulainen MH; Tuppurainen MT; Kröger H; Jurvelin J; Saarikoski S
Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
[TBL] [Abstract][Full Text] [Related]
7. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.
Niskanen L; Karvonen MK; Valve R; Koulu M; Pesonen U; Mercuri M; Rauramaa R; Töyry J; Laakso M; Uusitupa MI
J Clin Endocrinol Metab; 2000 Jun; 85(6):2266-9. PubMed ID: 10852461
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study.
Ilveskoski E; Viiri LE; Mikkelsson J; Pörsti I; Lehtimäki T; Karhunen PJ
Atherosclerosis; 2008 Aug; 199(2):445-50. PubMed ID: 18054939
[TBL] [Abstract][Full Text] [Related]
9. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients.
Pettersson-Fernholm K; Karvonen MK; Kallio J; Forsblom CM; Koulu M; Pesonen U; Fagerudd JA; Groop PH;
Diabetes Care; 2004 Feb; 27(2):503-9. PubMed ID: 14747236
[TBL] [Abstract][Full Text] [Related]
10. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes.
Jaakkola U; Kakko T; Seppälä H; Vainio-Jylhä E; Vahlberg T; Raitakari OT; Kallio J
Microvasc Res; 2010 Dec; 80(3):433-9. PubMed ID: 20691708
[TBL] [Abstract][Full Text] [Related]
11. Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.
Pesonen U; Koch W; Schömig A; Kastrati A
J Endovasc Ther; 2003 Jun; 10(3):566-72. PubMed ID: 12932169
[TBL] [Abstract][Full Text] [Related]
12. [Low prevalence of the Leu7/Pro polymorphism in the signal peptide of preproneuropeptide Y in the Spanish Mediterranean population].
Portolés O; Sorlí JV; González JI; Ruiz de la Fuente S; Ramírez JB; Corella D
Med Clin (Barc); 2003 Mar; 120(9):337-9. PubMed ID: 12646110
[TBL] [Abstract][Full Text] [Related]
13. The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprandial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet.
Schwab US; Agren JJ; Valve R; Hallikainen MA; Sarkkinen ES; Jauhiainen M; Karvonen MK; Pesonen U; Koulu M; Uusitupa MI; Savolainen MJ
Eur J Clin Nutr; 2002 Feb; 56(2):149-56. PubMed ID: 11857048
[TBL] [Abstract][Full Text] [Related]
14. The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test.
Jaakkola U; Kuusela T; Jartti T; Pesonen U; Koulu M; Vahlberg T; Kallio J
J Clin Endocrinol Metab; 2005 Jun; 90(6):3646-52. PubMed ID: 15797951
[TBL] [Abstract][Full Text] [Related]
15. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
Ukkola O; Kesäniemi YA
Eur J Clin Nutr; 2007 Sep; 61(9):1102-5. PubMed ID: 17268419
[TBL] [Abstract][Full Text] [Related]
16. Nutrient intake, weight, and Leu7Pro polymorphism in prepro-neuropeptide Y in children.
Karvonen MK; Ruottinen S; Koulu M; Pesonen U; Niinikoski H; Rask-Nissilä L; Simell O; Rönnemaa T
J Clin Endocrinol Metab; 2006 Nov; 91(11):4664-8. PubMed ID: 16912140
[TBL] [Abstract][Full Text] [Related]
17. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels.
Karvonen MK; Pesonen U; Koulu M; Niskanen L; Laakso M; Rissanen A; Dekker JM; Hart LM; Valve R; Uusitupa MI
Nat Med; 1998 Dec; 4(12):1434-7. PubMed ID: 9846584
[TBL] [Abstract][Full Text] [Related]
18. Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY.
Kallio J; Pesonen U; Karvonen MK; Kojima M; Hosoda H; Kangawa K; Koulu M
J Clin Endocrinol Metab; 2001 Nov; 86(11):5348-52. PubMed ID: 11701704
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.
Jaakkola U; Koulu M; Karvonen MK; Seppälä H; Pesonen U; Vahlberg T; Kallio J
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):281-6. PubMed ID: 17516289
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects--the cardiovascular risk in young Finns study.
Jaakkola U; Kakko T; Juonala M; Lehtimäki T; Viikari J; Jääskeläinen AE; Mononen N; Kähönen M; Koskinen T; Keltikangas-Järvinen L; Raitakari O; Kallio J
Neuropeptides; 2012 Dec; 46(6):321-8. PubMed ID: 23122776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
